Handelsavisen
prelaunch
Companies Healthcare WEED.TO
WE
WEED.TO Toronto Stock Exchange Pharmaceuticals

Canopy Growth Corp

C$1,41
Open in Charts → Attach watcher ⌖
CAD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
-35,2 %
ROE
-122,8 %
Net margin
-222,4 %
Debt / equity
0,67
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Canopy Growth Corp is a Canadian cannabis company that cultivates, produces, and sells cannabis and cannabis-derived products for medical and recreational use.

Business. Canopy Growth Corp (WEED.TO) is a healthcare company operating within the pharmaceuticals and medical research industry. The firm generates revenue through a product-sale model, focusing on activities related to pharmaceuticals and medical research. Headquartered in Canada, the company is primarily listed on the Toronto Stock Exchange under the ticker WEED.TO. Specific details regarding operating segments and geographic revenue mix are not available.

Classification92 %
SectorHealthcare
Business sectorPharmaceuticals & Medical Research
IndustryPharmaceuticals
ActivityPharmaceuticals & Medical Research
Generated · model-assisted
Sell-side consensus
HOLD6 analysts
2 buy3 hold1 sell
Avg 12m price target2,36

Analyst recommendations

6 analysts · consensus Hold
Buy2
Hold3
Sell1
12-month price target
2,36
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Hold
6 analysts · indicative
Ownership
UBS Financial Services, Inc.
largest disclosed fund holder
Profitability
-122,8 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning WEED.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to WEED.TO. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    Briefing · model-assisted

    Canopy Growth Corp (WEED.TO) has entered the analytical scope for the first time, establishing a baseline for future monitoring. As this is the initial analysis for the ticker, there is no prior data to compute material changes or deltas, meaning current observations serve as the foundational reference point for the company's financial and operational profile. The most notable activity involves a major severity signal regarding a holder change for investor ID 587. Data detected on June 20, 2026, indicates a modification in shareholding from 9 shares to 610 shares as of March 31, 2026. This was followed by a subsequent modification detected on June 21, 2026, showing the position reverting from 610 shares back to 9 shares for the same reporting period. These rapid, conflicting adjustments in the same investor's reported holdings highlight significant data volatility or correction activity within the shareholder registry. Despite these holder fluctuations, the broader institutional landscape remains sparse. Canopy Growth currently has only one analyst covering the stock and zero index memberships, suggesting limited mainstream financial integration. The company maintains a top holder count of 11, but the specific details of these major stakeholders are not fully elaborated beyond the anomalous activity of investor ID 587. This initial snapshot underscores the importance of data verification for Canopy Growth, particularly given the erratic reporting from a single investor. With no cross-source signals or sagas to provide additional context, the current view is defined by this lack of historical comparison and the specific, volatile holder changes. Investors should monitor whether these data corrections stabilize as more comprehensive financial, estimate, and ESG data becomes available.

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Canopy Growth Corp (WEED.TO) is a healthcare company operating within the pharmaceuticals and medical research industry. The firm generates revenue through a product-sale model, focusing on activities related to pharmaceuticals and medical research. Headquartered in Canada, the company is primarily listed on the Toronto Stock Exchange under the ticker WEED.TO. Specific details regarding operating segments and geographic revenue mix are not available.

    Classification92 %
    SectorHealthcare
    Business sectorPharmaceuticals & Medical Research
    IndustryPharmaceuticals
    ActivityPharmaceuticals & Medical Research
    AI synthesis
    GENERATED

    Canopy Growth Corp has a debt-to-equity ratio of 0.67 and a current ratio of 3.12, indicating moderate leverage and strong short-term liquidity. However, the company's cash and equivalents amount to only CAD 130,000, which is significantly lower than its long-term debt of CAD 325,267,000, suggesting a liquidity risk.

    The company's profitability metrics are weak, with a return on equity of -1.2276 and a return on assets of -0.6518, both well below the industry median for pharmaceutical companies. These figures indicate that the company is not generating returns for shareholders or effectively utilizing its assets.

    Canopy Growth Corp's revenue is concentrated in a single business segment, cannabis cultivation and sales, with no disclosed geographic diversification. This concentration increases exposure to regulatory and market risks in the cannabis industry.

    The company's growth trajectory is uncertain, with no disclosed revenue growth in the most recent fiscal year. Analysts have provided a mean price target of CAD 2.36 and a median price target of CAD 1.80, with a mean recommendation of 2.83, indicating a mixed outlook.

    The company's risk assessment highlights a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt underscores the company's financial vulnerability.

    Recent events include a continued focus on cost reduction and operational efficiency, as disclosed in the company's latest financial filings. No major new product launches or strategic acquisitions were reported in the most recent quarter.

    Canopy Growth Corp (WEED.TO) has entered the analytical scope for the first time, establishing a baseline for future monitoring. As this is the initial analysis for the ticker, there is no prior data to compute material changes or deltas, meaning current observations serve as the foundational reference point for the company's financial and operational profile. The most notable activity involves a major severity signal regarding a holder change for investor ID 587. Data detected on June 20, 2026, indicates a modification in shareholding from 9 shares to 610 shares as of March 31, 2026. This was followed by a subsequent modification detected on June 21, 2026, showing the position reverting from 610 shares back to 9 shares for the same reporting period. These rapid, conflicting adjustments in the same investor's reported holdings highlight significant data volatility or correction activity within the shareholder registry. Despite these holder fluctuations, the broader institutional landscape remains sparse. Canopy Growth currently has only one analyst covering the stock and zero index memberships, suggesting limited mainstream financial integration. The company maintains a top holder count of 11, but the specific details of these major stakeholders are not fully elaborated beyond the anomalous activity of investor ID 587. This initial snapshot underscores the importance of data verification for Canopy Growth, particularly given the erratic reporting from a single investor. With no cross-source signals or sagas to provide additional context, the current view is defined by this lack of historical comparison and the specific, volatile holder changes. Investors should monitor whether these data corrections stabilize as more comprehensive financial, estimate, and ESG data becomes available.

    Key takeaways
    • Canopy Growth Corp has a weak return on equity and return on assets, indicating poor profitability.
    • The company's liquidity is constrained by low cash reserves relative to its debt.
    • Revenue is concentrated in a single business segment, increasing exposure to industry-specific risks.
    • Analysts have a mixed outlook, with a mean price target of CAD 2.36 and a median price target of CAD 1.80.
    • The company faces a medium liquidity risk and a low dilution risk.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    C$1,41
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    C$487.2M
    Net cash
    -C$325.1M
    Current ratio
    3.1
    Debt / equity
    0.7
    ROA
    -65.2%
    ROE
    -1.2%
    Cash conversion
    28.0%
    CapEx / revenue
    -4.2%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    -0,47
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    6
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-25 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate-0,47
    Revenueno estimateno estimate285,5M CAD
    Operating incomeno estimateno estimate-80,5M CAD
    Full-year consensus mean (period as reported by source) · consensus in CAD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Corporate eventM&A horizon
    M&A probabilityconf 3 %
    Probability
    3 %
    Base rate
    3 %
    Band
    180-day horizon · target 2027-01-16 · 1,0× base rate
    No acquirer candidates identified by the signal model.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution6 analysts
    Strong buy0
    Buy2
    Hold3
    Sell1
    Strong sell0
    12-month price targetC$2,36 · Median C$1,80
    Low C$1,40High C$5,00
    Operating income · consensus-80,5M CAD
    EPS surprise
    −1 093,1 %
    reported vs consensus · miss
    Revenue surprise
    +10,0 %
    reported vs consensus · beat

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    LowC$1,40
    MeanC$2,36
    MedianC$1,80
    HighC$5,00
    SpotC$1,41
    +67.4 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-35,2 %Bottom quartile
    Net Margin-222,3 %Bottom quartile
    ROE-122,8 %Bottom quartile
    Capex / Rev-4,2 %Above median
    D/E0,67Bottom quartile
    Cash Conv0,28Below median

    Corporate actions / M&A

    M&A probabilityconf —
    Probability
    3 %
    Base rate
    3 %
    Band
    Low
    180-day horizon · target 2027-01-16 · 1,0× base rate
    No acquirer candidates identified by the signal model.
    Corporate actionsNo corporate-action source connected yet — splits, dividends and buyback events are not tracked for this company. Honest-dim (no data fabricated).

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Canopy Growth Corp Market data — financials · 2026-05-30
    • Canopy Growth Corp Market data — analyst estimates · 2026-05-30
    • Canopy Growth Corp Market data — ESG · 2026-05-30

    Ownership & reference

    Top holders

    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$1M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$1M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$2M
    • LPL Financial LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,00 %$0M
    • AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,00 %$0M
    • Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,00 %$0M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$0M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,00 %$0M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M

    Insider activity

    — missing data

    Short positioning

    589shares short-46.9% vs prior
    1days to cover
    41.1%short of daily vol
    252fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    WEED.TOCanonical
    Toronto Stock Exchange · CAD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00M&A prob3 %Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: ma_probability (180d)
    2026-06-21 02:57 UTCHOLDERInstitutional holding changed
    2026-06-21 02:57 UTCHOLDERInstitutional holding changed
    2026-06-21 02:57 UTCHOLDER2 institutional position changes flagged (2 major)
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage